CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

More than 69.2 million FDA-approved weight-loss prescriptions were dispensed in the U.S. from July 2017 through February 2024 ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

A study has suggested that weight-loss injections may be linked to broader ... discovered that participants who used drugs such as Wegovy and Ozempic had a lower risk of 42 health conditions ...